期刊文献+

高截留量血液透析清除多发性骨髓瘤血清游离轻链4例 被引量:3

下载PDF
导出
摘要 高截留量血液透析即采用高截留量膜进行的血液透析。高截留量膜通常是指膜孔径8~10 nm的透析膜,是高通量膜孔径的2~3倍,血浆分离器膜孔径的1/20[1]。高截留量透析对大分子物质清除具有显著的优势,临床应用日趋增多。本研究对高截留量透析有效清除多发性骨髓瘤血清游离轻链的4例患者进行报道。
作者 孙小伟
出处 《山东医药》 CAS 2014年第20期94-95,共2页 Shandong Medical Journal
  • 相关文献

参考文献5

  • 1Haase M, Bellomo R, Morgera S,' et al. High cut-off point mem- branes in septic acute renal failure: a systematic review [ J ]. Int J Artif Organs, 2007,30 ( 12 ) : 1031-1041.
  • 2龚德华,季大玺,张凯悦,黄湘华,黄高渊,徐斌,刘志红.高截留量透析治疗多发性骨髓瘤:个案报道[J].肾脏病与透析肾移植杂志,2012,21(4):324-329. 被引量:9
  • 3Ouseph R, Hutchison CA, Ward RA. Differences in solute removal by two high-flux membranes of nominally similar synthetic polymers [ J ]. Nephrol Dial Transplant, 2008,23 (5) : 1704-1712.
  • 4Hutchison CA, Cockwell P, Reid S, et al. Efficient removal of im- munoglobulin free light chains by hemodialysis for multiple myelo- ma: in vitro and in vivo studies[J]. J Am Soc Nephrol, 2007,18 (3) :886-895.
  • 5Hutchison CA, Cook M, Heyne N, et al. European trial of free light chain removal by extended haemodialysis in east nephropathy (Eu- LITE) : a randomised control trial[ J]. Trials. 2008,9 :55.

二级参考文献32

  • 1Wirk B. Renal failure in muhiple myeloma: a medical emergency. Bone Marrow Transplant,2011,46 (6) :771 - 783.
  • 2Katagiri D, Hagiwara S, Minami E, et al. Factors associated with recovery of renal function in patients with multiple myeloma who were treated with hemodialysis. Nephron Clin Pract, 2011, 117 (1) :e28 -32.
  • 3Gakhar B, Kobrin S, Berns JS. Extracorporeal treatment of cast nephropathy. Semi n Dial,2011,24 ( 1 ) :9 - 11. Cserti C, Haspel R, Stowell C, et al. Light-chain removal by plasmapheresis in myeloma-associated renal failure. Transfusion, 2007,47(3) :511 -514.
  • 4Cserti C, Haspel R, Stowell C, et al. Light-chain removal by plasmapheresis in myeloma-associated renal failure. Transfusion, 2007,47(3) :511 -514.
  • 5Mahmood A, Sodano D, Dash A, et al. Therapeutic plasma exchange performed in tandem with hemodialysis for patients with M-protein disorders. J Clin Apher,2006,21 ( 2 ) : 100 - 104.
  • 6Hutchison CA,Bradwell AR, Cook M, et al. Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis. Clin J Am Soc Nephrol, 2009,4 (4) :745 -754.
  • 7Hutehison CA, Harding S, Mead G, et al. Serum free-light chain removal by high cutoff hemodialysis: optimizing removal and supportive care. Artif Organs,2008,32 ( 12 ) :910 - 917.
  • 8Hutchison CA, Coekwell P, Reid S, et al. Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma:in vitro and in vivo studies. J Am Soc Nephrol, 2007,18 (3) :886 -895.
  • 9Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt./V :an analysis of error. J Am Soc Nephrol, 1993,4 (5) :1205 -1213.
  • 10Sorrentino SA, Kielstein JT, Lukasz A, et al. High permeability dialysis membrane allows effective removal of myoglobin in acute kidney injury resulting from rhabdomyolysis. Crit Care Med, 2011, 39 (1) :184 -186.

共引文献8

同被引文献12

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部